Overview of pathophysiology and rationale for treatment of sickle cell anemia
- Author
- RODGERS, G. P1
[1] Hematology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States - Conference title
- Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children
- Conference name
- Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children (Orlando, FL 1996-12-06)
- Author (monograph)
- ROGERS, Zora R (Editor)1 2
University of Texas ; Southwestern Medical Center ; Department of Pediatrics, Dallas, TX, United States (Funder/Sponsor)
[1] Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX, United States
[2] Pediatric Sickle Cell Program, Children's Medical Center of Dallas, Dallas, TX, United States - Source
Seminars in hematology. 1997, Vol 34, Num 3, pp 2-7 ; SUP3 ; ref : 22 ref
- CODEN
- SEHEA3
- ISSN
- 0037-1963
- Scientific domain
- Hematology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Anémie hématie falciforme Biologie cellulaire Biologie moléculaire Désoxygénation Déterminisme génétique Evolution Expression génique Homme Hémoglobine S Hémolyse Physiopathologie Propriété rhéologique Anémie hémolytique Hémoglobinopathie Hémopathie Maladie héréditaire
- Keyword (en)
- Sickle cell anemia Cell biology Molecular biology Deoxygenation Genetic inheritance Evolution Gene expression Human Hemoglobin S Hemolysis Pathophysiology Rheological properties Hemolytic anemia Hemoglobinopathy Hemopathy Genetic disease
- Keyword (es)
- Anemia glóbulo falciforme Biología celular Biología molecular Desoxigenación Determinismo genético Evolución Expresión genética Hombre Hemoglobina S Hemólisis Fisiopatología Propiedad rheológica Anemia hemolítica Hemoglobinopatía Hemopatía Enfermedad hereditaria
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19A Diseases of red blood cells / 002B19A01 Anemias. Hemoglobinopathies
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2833910
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:1:\"2\";s:8:\"\u0000*\u0000epage\";s:1:\"7\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"RODGERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:93:\"Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children\";s:8:\"\u0000*\u0000title\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:1:\"2\";s:8:\"\u0000*\u0000epage\";s:1:\"7\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"RODGERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:93:\"Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children\";s:8:\"\u0000*\u0000title\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:1:\"2\";s:8:\"\u0000*\u0000epage\";s:1:\"7\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"RODGERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:93:\"Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children\";s:8:\"\u0000*\u0000title\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:1:\"2\";s:8:\"\u0000*\u0000epage\";s:1:\"7\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"RODGERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:93:\"Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children\";s:8:\"\u0000*\u0000title\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:1:\"2\";s:8:\"\u0000*\u0000epage\";s:1:\"7\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"RODGERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:93:\"Clinical Update on Hydroxyurea in the Management of Sickle Cell Anemia in Adults and Children\";s:8:\"\u0000*\u0000title\";s:77:\"Overview of pathophysiology and rationale for treatment of sickle cell anemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
